News
13hon MSN
Missing messenger RNA fragments could be key to new immunotherapy for hard-to-treat brain tumors
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that ...
The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...
A new study, led by researchers at Children's Hospital of Philadelphia (CHOP), identified tiny pieces of messenger RNA that are missing in pediatric high-grade glioma tumors but not in normal brain ...
Scientists say HHS’s decision to stop investing in mRNA vaccine research is another sign of the growing politicization of ...
Federal funding cuts to mRNA technology research doesn't just impact COVID vaccines — experts say it could stall progress in ...
The rest of the world is not following the US government’s dangerous path, and will stick with the technology that helped the ...
17h
ZME Science on MSNSome People Are Immune to All Viruses. Scientists Now Want To Replicate This Ability for a Universal Antiviral
Mutatation causes immunity to all viruses and researchers now want to build a treatment from it.
Shares of the biotech Moderna were up on Wednesday, as the Trump administration’s shifting position on messenger RNA-based ...
The Trump administration’s decision to halt nearly $500 million for mRNA vaccine research has made investors more hesitant to ...
NIH director Jay Bhattacharya has offered a new explanation for why the federal government canceled $500 million in contracts ...
HHS is slashing hundreds of millions in funding for mRNA vaccines and infectious disease treatments, but leaving the door ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results